Autopsy report · NCT02568826

Tolerability, Safety and Activity of a Muscle Relaxant Molecule IDN5243 in Patients With Low Back Pain

“No patients enrolled in the study.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Indena S.p.A

Sponsor type

Industry

Conditions

Low Back Pain

Interventions

3-glycosyl-3-Odemethylthiocolchicine derivative

Participants

0

Sites

1

Countries

Italy

Trials that died the same way

• Pulmozyme for Sjogren's Associated Cough
  “No patients enrolled.” (94% match in meaning)
• Use of the INAMED LAPBAND System to Reduce BMI's in Obese Renal Failure Patients
  “No patients were enrolled.” (93% match in meaning)
• Effects of Atomized Dexmedetomidine on Lung Function in Patients With Chronic Obstructive Pulmonary Disease
  “no patient enrolled.” (90% match in meaning)
• Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia
  “No eligible patients were enrolled.” (89% match in meaning)
• Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast Cancer
  “No patients recruited.” (87% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.